SEI Trust Company’s Achillion Pharmaceuticals ACHN Stock Holding History

SEI Trust Company’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$265K	Buy	+26,558	New	+$247K	﹤0.01%	1248
2013 Q4	–	Sell	-41,345	Closed	-$125K	–	1680
2013 Q3	$125K	Buy	41,345 +6,830	+20%	+$46.8K	﹤0.01%	1374
2013 Q2	$282K	Buy	+34,515	New	+$263K	﹤0.01%	1053

Other funds holding ACHN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SEI Trust Company's ACHN Position: Q3 2014 in Review

SEI Trust Company opened a new position in Achillion Pharmaceuticals (ACHN) in Q3 2014: 26,558 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #1248 among its holdings. This is a return to the name: SEI Trust Company previously reported a position in ACHN as recently as Q3 2013.

SEI Trust Company first reported a position in ACHN in Q2 2013 and has held it in 3 quarters since. The position peaked at $282K in Q2 2013. 161 funds tracked by Wall St. Rank hold ACHN as of Q3 2014.

SEI Trust Company held 26,558 shares of Achillion Pharmaceuticals worth $265K as of Q3 2014.
Achillion Pharmaceuticals was a new SEI Trust Company position in Q3 2014.
Achillion Pharmaceuticals made up ﹤0.01% of SEI Trust Company's portfolio in Q3 2014, its #1248 holding.
SEI Trust Company first reported a position in Achillion Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
SEI Trust Company's Achillion Pharmaceuticals position peaked at $282K in Q2 2013.
161 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.